Antibacterial agent 134
Antibacterial agent 134 is the major metabolite in the culture of Hymeniacidon perleve associated bioactive bacterium Pseudomonas sp. NJ6-3-1. Antibacterial agent 134 can be used for bacterial infection.
For research use only. We do not sell to patients.
- CAS No.: 14474-71-6
- Formula: C14H18N2O2
- Molecular Weight:246.30
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
All Endogenous Metabolite Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
Microbial Metabolite |
In Vitro
Antibacterial agent 134 (Compound 1), isolated from Pseudomonas sp. NJ6-3-1 culture broth, can exert antibacterial effects together with other metabolites of Pseudomonas sp. NJ6-3-1[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 14474-71-6
-
Molecular Weight 246.30
-
Formula C14H18N2O2
-
SMILES
O=C(C(C(C)C)N1)NC(CC2=CC=CC=C2)C1=O
-
Structure Classification
-
Initial Source
Pseudomonas sp.
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Antibacterial agent 134 Related Classifications
HY-142075 Related Classifications
Powered by Bioz